Clinical Trial Update: Toward Personalized Medicine to Guide Drug Withdrawal in Children with Juvenile Idiopathic Arthritis in Clinical Remission [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial from Istituto Giannina Gaslini aims to personalize when to withdraw therapy for children with juvenile idiopathic arthritis who are in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Snippet

Sponsor: Istituto Giannina Gaslini | Conditions: Juvenile Idiopathic Arthritis (JIA) | Phase 4 | Status: NOT_YET_RECRUITING